Atea Pharmaceuticals
AVIR | NASDAQ
$4.12
-$0.18 (-4.19%)
At close: Nov 16, 2026, 4:00 PM ET
$4.12
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-4.19%
(1D)No price chart data available for 1D timeframe.
Rating
23.5
-3.0 ptsFundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #956/1021 (Top 94%)
Key Statistics
Market Data
Market Cap $330.85M
1D Range
4.10 4.38
52W Range
2.97 6.15
Valuation (TTM)
PE -2.11
PB 1.88
EV/EBITDA -0.87
Valuation (NTM)
Forward PE N/A
Forward PEG 0.85
Price Target $7.00
Cash Flow
FCF Yield -42.5%
SBC Adj. FCF Yield -47.1%
SBC Impact -10.8%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
-100.0%
Dil EPS 3Y | 5Y 3.1% |
-34.3%
FCF 3Y | 5Y -5.1% |
1.8%
Returns
ROA -77.4%
ROE -69.9%
ROIC -93.8%
Financial Health
Net Cash
$191.2M
Current Ratio 8.00
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections. Its lead product...
Sector Healthcare
Industry Biotechnology
Employees 55
IPO Date Oct 30, 2020
Website www.ateapharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
2
Consensus
Hold
Price Target
$7.00
Upside
+69.90%
Buy (1)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove AVIR